Pharmacokinetics, efficacy, and safety of patritumab deruxtecan (HER3-DXd) in EGFR inhibitor-resistant, EGFR-mutated (EGFRm) non-small cell lung cancer (NSCLC) Meeting Abstract
| Authors: | Yu, H. A.; Cantero, F.; Kim, B.; Lee, M.; Wu, E.; Sternberg, D. W.; Jänne, P. A. |
| Abstract Title: | Pharmacokinetics, efficacy, and safety of patritumab deruxtecan (HER3-DXd) in EGFR inhibitor-resistant, EGFR-mutated (EGFRm) non-small cell lung cancer (NSCLC) |
| Meeting Title: | ESMO Congress 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2022 Sep 9-13 |
| Meeting Location: | Paris, France |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-09-01 |
| Start Page: | S1092 |
| End Page: | S1093 |
| Language: | English |
| ACCESSION: | WOS:000866211601452 |
| DOI: | 10.1016/j.annonc.2022.07.1313 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1190TiP -- Source: Wos |
